Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|February 1, 1997
Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlationsM J Calasanz, J C Cigudosa, M D Odero, et al.
Oncogene|January 9, 2004
Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cellsIdoya Lahortiga, Xabier Agirre, Elena Belloni, et al.
Molecular Immunology|March 25, 2015
New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2Teresa Laguna, Laura Notario, Raffaella Pippa, et al.
Genes, Chromosomes & Cancer|August 31, 2002
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndromeMaría D Odero, José L Vizmanos, José P Román, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesJosé L Vizmanos, Roberto Hernández, María J Vidal, et al.
Cancer Genetics and Cytogenetics|May 15, 2007
Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenesBorja Sáez, José I Martín-Subero, Idoya Lahortiga, et al.
Cancer Genetics and Cytogenetics|May 23, 2001
Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridizationJ I Martín-Subero, I Lahortiga, E Gómez, et al.
Blood|December 8, 2009
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemiaIon Cristóbal, Francisco J Blanco, Laura Garcia-Orti, et al.
Leukemia|December 25, 2004
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignanciesM D Odero, F H Grand, S Iqbal, et al.
Cancer Research|June 18, 2003
NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)Idoya Lahortiga, José L Vizmanos, Xabier Agirre, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|February 1, 1997
Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlationsM J Calasanz, J C Cigudosa, M D Odero, et al.
Oncogene|January 9, 2004
Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cellsIdoya Lahortiga, Xabier Agirre, Elena Belloni, et al.
Molecular Immunology|March 25, 2015
New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2Teresa Laguna, Laura Notario, Raffaella Pippa, et al.
Genes, Chromosomes & Cancer|August 31, 2002
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndromeMaría D Odero, José L Vizmanos, José P Román, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesJosé L Vizmanos, Roberto Hernández, María J Vidal, et al.
Cancer Genetics and Cytogenetics|May 15, 2007
Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenesBorja Sáez, José I Martín-Subero, Idoya Lahortiga, et al.
Cancer Genetics and Cytogenetics|May 23, 2001
Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridizationJ I Martín-Subero, I Lahortiga, E Gómez, et al.
Blood|December 8, 2009
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemiaIon Cristóbal, Francisco J Blanco, Laura Garcia-Orti, et al.
Leukemia|December 25, 2004
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignanciesM D Odero, F H Grand, S Iqbal, et al.
Cancer Research|June 18, 2003
NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)Idoya Lahortiga, José L Vizmanos, Xabier Agirre, et al.
Pageof 8